Frankfurt - Delayed Quote EUR

Insulet Corporation (GOV.F)

263.40
+2.40
+(0.92%)
At close: June 13 at 9:55:01 PM GMT+2

Research Analysis

Revenue vs. Earnings

Revenue 569M
Earnings 73.7M

Q2'24

Q3'24

Q4'24

Q1'25

0
200M
400M
 

Analyst Price Targets

Earnings Estimate

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts --------
Avg. Estimate 0000
Low Estimate 0000
High Estimate 0000
Year Ago EPS --------

Revenue Estimate

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts 19192323
Avg. Estimate 612.13M644.73M2.52B2.96B
Low Estimate 576.2M627.7M2.43B2.83B
High Estimate 619M659.63M2.57B3.1B
Year Ago Sales 488.5M543.9M2.07B2.52B
Sales Growth (year/est) 25.31%18.54%21.63%17.64%

EPS Trend

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Current Estimate 0000
7 Days Ago 0000
30 Days Ago 0000
60 Days Ago 0000
90 Days Ago 0000

EPS Revisions

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
GOV.F --------
S&P 500 13.13%2.41%7.55%14.06%

Upgrades & Downgrades

Initiated Goldman Sachs: Buy 5/30/2025
Maintains Raymond James: Outperform to Outperform 5/27/2025
Maintains Citigroup: Buy to Buy 5/22/2025
Upgrade Wolfe Research: Peer Perform to Outperform 5/13/2025
Maintains Oppenheimer: Outperform to Outperform 5/9/2025
Maintains Barclays: Equal-Weight to Equal-Weight 4/30/2025